Hear what international experts think the greatest medical challenges are, and how they can be met using new technologies to unravel the secrets of illness and create the means whereby we can all live longer, healthier lives, at this exciting international conference. One of the prominent sessions included in this event is Commercialising Nanotechnology.

Commercialising Nanotechnology Session

The purpose of this session is to examine the commercialisation issues associated with research, development, manufacturing and marketing of new medical products such as diagnostic devices, surgical instruments and equipment. Experts will give short presentations followed by a panel discussion for delegates to ask questions and feedback their views.

Speakers will include:

«Successful Commercialization - The Ultimate Goal»
Dr. Robert Mehalso, President, Microtec Associates & Executive Chairman, Oxford Biosensors, USA

«Six Disruptive Products in Medical and Biomedical Markets based on MNT»
Dr. Malcolm Wilkinson, Technology For Industry Ltd, UK

«How to Make a Successful Diagnostic Product from MNT»
Dr Andrew Campitelli, MiniFAB (AUST) Pty Ltd, Australia

«Medimate, Commercialization of a Microfluidic Device to Monitor Lithium in Blood, as a Self Test at Home or at the Doctor's Office»
Steven Staal, Medimate BV , The Netherlands

«Microfluidics for Medical Diagnostics, Opportunities and Barriers for Commercialization»
Henne van Heeren, enablingMNT, Germany

For further information contact:
carrie.smith@nano.org.uk
or www.nano.org.uk
or telephone: 44 (0)141 303 8444

Tutto su: Nanotechnology, Nanotecnologie, Science, Scienza